| Statements from the Taormina expert meeting on occult hepatitis B virus infection G Raimondo, JP Allain, MR Brunetto, MA Buendia, DS Chen, M Colombo, ... Journal of hepatology 49 (4), 652-657, 2008 | 1158 | 2008 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1123 | 2019 |
| Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis X Liu, P Invernizzi, Y Lu, R Kosoy, Y Lu, I Bianchi, M Podda, C Xu, G Xie, ... Nature genetics 42 (8), 658-660, 2010 | 471 | 2010 |
| Comparison of the clinical features and clinical course of antimitochondrial antibody‐positive and‐negative primary biliary cirrhosis P Invernizzi, A Crosignani, PM Battezzati, G Covini, G De Valle, A Larghi, ... Hepatology 25 (5), 1090-1095, 1997 | 344 | 1997 |
| International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways HJ Cordell, Y Han, GF Mells, Y Li, GM Hirschfield, CS Greene, G Xie, ... Nature communications 6 (1), 8019, 2015 | 317 | 2015 |
| Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis M Longo, A Crosignani, PM Battezzati, CS Giussani, P Invernizzi, M Zuin, ... Gut 51 (2), 265-269, 2002 | 227 | 2002 |
| X chromosome monosomy: a common mechanism for autoimmune diseases P Invernizzi, M Miozzo, C Selmi, L Persani, PM Battezzati, M Zuin, ... The journal of immunology 175 (1), 575-578, 2005 | 222 | 2005 |
| Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis J Wesierska‐Gadek, E Penner, PM Battezzati, C Selmi, M Zuin, ... Hepatology 43 (5), 1135-1144, 2006 | 216 | 2006 |
| Predicting Mortality Risk in Patients With Compensated HCV-lnduced Cirrhosis: A Long-Term Prospective Study S Bruno, M Zuin, A Crosignani, S Rossi, F Zadra, L Roffi, M Borzio, ... Official journal of the American College of Gastroenterology| ACG 104 (5 …, 2009 | 203 | 2009 |
| Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis P Invernizzi, M Podda, PM Battezzati, A Crosignani, M Zuin, E Hitchman, ... Journal of hepatology 34 (3), 366-372, 2001 | 182 | 2001 |
| Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between … BD Juran, GM Hirschfield, P Invernizzi, EJ Atkinson, Y Li, G Xie, R Kosoy, ... Human molecular genetics 21 (23), 5209-5221, 2012 | 179 | 2012 |
| Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone M Podda, M Zuin, PM Battezzati, C Ghezzi, C De Fazio, ML Dioguardi Gastroenterology 96 (1), 222-229, 1989 | 176 | 1989 |
| Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis M Miozzo, C Selmi, B Gentilin, FR Grati, S Sirchia, S Oertelt, M Zuin, ... Hepatology 46 (2), 456-462, 2007 | 151 | 2007 |
| Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration A Crosignani, M Podda, PM Battezzati, E Bertolini, M Zuin, D Watson, ... Hepatology 14 (6), 1000-1007, 1991 | 146 | 1991 |
| Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C R D'Ambrosio, L Pasulo, M Puoti, M Vinci, M Schiavini, S Lazzaroni, ... Journal of hepatology 70 (3), 379-387, 2019 | 143 | 2019 |
| Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy CA Caserta, GM Pendino, A Amante, C Vacalebre, MT Fiorillo, P Surace, ... American journal of epidemiology 171 (11), 1195-1202, 2010 | 134 | 2010 |
| Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score M Carbone, A Nardi, S Flack, G Carpino, N Varvaropoulou, C Gavrila, ... The Lancet Gastroenterology & Hepatology 3 (9), 626-634, 2018 | 133 | 2018 |
| Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis M Podda, C Ghezzi, PM Battezzati, A Crosignani, M Zuin, A Roda Gastroenterology 98 (4), 1044-1050, 1990 | 129 | 1990 |
| Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies A Larghi, M Zuin, A Crosignani, ML Ribero, C Pipia, PM Battezzati, ... Hepatology 36 (4), 993-1000, 2002 | 124 | 2002 |
| Defective regulation of cholangiocyte Cl−/HCO [overthree] and Na+/H+ exchanger activities in primary biliary cirrhosis S Melero, C Spirlı, A Zsembery, JF Medina, RE Joplin, E Duner, M Zuin, ... Hepatology 35 (6), 1513-1521, 2002 | 122 | 2002 |
